Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4(+) T cells into the infarcted heart via CCL5/CCR5 signaling

BACKGROUND: Human umbilical cord-derived mesenchymal stem cells (HucMSCs) have been recognized as a promising cell for treating myocardial infarction (MI). Inflammatory response post MI is critical in determining the cardiac function and subsequent adverse left ventricular remodeling. However, the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Liang, Xiaoting, Li, Mimi, Lin, Fang, Ma, Xiaoxue, Xin, Yuanfeng, Meng, Qingshu, Zhuang, Rulin, Zhang, Qingliu, Han, Wei, Gao, Ling, He, Zhiying, Zhou, Xiaohui, Liu, Zhongmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188247/
https://www.ncbi.nlm.nih.gov/pubmed/35690805
http://dx.doi.org/10.1186/s13287-022-02914-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188247/
https://www.ncbi.nlm.nih.gov/pubmed/35690805
http://dx.doi.org/10.1186/s13287-022-02914-z

Ejemplares similares